These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15379603)

  • 1. Cytokines in the central nervous system: targets for therapeutic intervention.
    Safieh-Garabedian B; Haddad JJ; Saadé NE
    Curr Drug Targets CNS Neurol Disord; 2004 Aug; 3(4):271-80. PubMed ID: 15379603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors are key players in neurodegeneration.
    Arroyo DS; Soria JA; Gaviglio EA; Rodriguez-Galan MC; Iribarren P
    Int Immunopharmacol; 2011 Oct; 11(10):1415-21. PubMed ID: 21616174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory mechanism of ginseng saponins in activated microglia.
    Park JS; Park EM; Kim DH; Jung K; Jung JS; Lee EJ; Hyun JW; Kang JL; Kim HS
    J Neuroimmunol; 2009 Apr; 209(1-2):40-9. PubMed ID: 19232442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytokines in the regulation of neurotransmission.
    Camacho-Arroyo I; López-Griego L; Morales-Montor J
    Neuroimmunomodulation; 2009 Jan; 16(1):1-12. PubMed ID: 19077440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
    Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors in neurodegeneration.
    Okun E; Griffioen KJ; Lathia JD; Tang SC; Mattson MP; Arumugam TV
    Brain Res Rev; 2009 Mar; 59(2):278-92. PubMed ID: 18822314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity: the missing link in neuroprotection and neurodegeneration?
    Nguyen MD; Julien JP; Rivest S
    Nat Rev Neurosci; 2002 Mar; 3(3):216-27. PubMed ID: 11994753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical inflammation in the central nervous system in prion disease.
    Perry VH; Cunningham C; Boche D
    Curr Opin Neurol; 2002 Jun; 15(3):349-54. PubMed ID: 12045736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation".
    Dalakas MC
    Ann Neurol; 2008 Jul; 64(1):1-3. PubMed ID: 18626972
    [No Abstract]   [Full Text] [Related]  

  • 10. Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease.
    Norden DM; Muccigrosso MM; Godbout JP
    Neuropharmacology; 2015 Sep; 96(Pt A):29-41. PubMed ID: 25445485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity.
    Thompson KK; Tsirka SE
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
    Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory potential of thymosin β4 in the central nervous system: implications for progressive neurodegenerative diseases.
    Pardon MC
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):165-169. PubMed ID: 30063850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
    Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
    Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of microRNA in microglia-mediated immune response.
    Guedes J; Cardoso AL; Pedroso de Lima MC
    Clin Dev Immunol; 2013; 2013():186872. PubMed ID: 23762086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of interleukin-1beta by interleukin-4 in lipopolysaccharide-treated mixed glial cultures: microglial-dependent effects.
    Cao L; Fei L; Chang TT; DeLeo JA
    J Neurochem; 2007 Jul; 102(2):408-19. PubMed ID: 17442043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of microglial survival and proliferation in health and diseases.
    Ulland TK; Wang Y; Colonna M
    Semin Immunol; 2015 Dec; 27(6):410-5. PubMed ID: 27033414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in central nervous system injury.
    Allan SM; Rothwell NJ
    Philos Trans R Soc Lond B Biol Sci; 2003 Oct; 358(1438):1669-77. PubMed ID: 14561325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approaches to inflammation in neurodegenerative disease.
    Klegeris A; McGeer EG; McGeer PL
    Curr Opin Neurol; 2007 Jun; 20(3):351-7. PubMed ID: 17495632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.